A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014179)

This study is currently recruiting participants.

Study NCT00488631 Information provided by Centocor, Inc.

First Received: June 18, 2007 Last Updated: November 19, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2017
Estimated Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)